AI assistant
Sending…
RESMED INC — Director's Dealing 2014
Apr 3, 2014
30071_dirs_2014-04-03_798b3c3b-9096-42fa-aebc-af18915b6f47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-04-01
Reporting Person: Hollingshead James (President, Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-01 | ResMed Common Stock | M | 7144 | $45.24 | Acquired | 33428.735 | Direct |
| 2014-04-01 | ResMed Common Stock | F | 2689 | $45.24 | Disposed | 30739.735 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-01 | ResMed Performance RSUs | $0 | M | 7144 | Disposed | ResMed Common Stock (7144) | Direct |
Footnotes
F1: RSUs do not have an expiration date.
F2: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 4/1/2010.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29